Migraine
📧 Sign up to get email alerts when something new happens for Migraine.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Effect of Breathing Techniques on Migraine Attacks and Severity [NA]
A completed clinical trial evaluating whether breathing techniques can reduce migraine attack frequency and severity.
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Trigeminal Brainstem Mapping 2: Higher Cortical Strucureas As Well As Subnuclei of the Spinal Trigeminal Nucleus [NA]
A clinical trial update for a trigeminal brainstem mapping study in migraine disorders, currently recruiting at Universitätsklinikum Hamburg…
-
FDA approval · 2024-09-10FDA Approved: TOPIRAMATE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for Topiramate from Zydus Lifesciences Limited, granting approval for a generic version of the anti-…
-
CLINICAL_TRIALS trial_result · 2024-09-05Clinical Trial Update: Effectiveness of a Dialogue-based Online Intervention Against Migraine [NA]
A completed clinical trial evaluated the effectiveness of a dialogue-based online intervention for migraine. The study was sponsored by Gaia…
-
CLINICAL_TRIALS research · 2024-09-05Clinical Trial Update: Biochemical Profiling of Migraine Patients
A clinical trial update describing biochemical profiling in migraine patients; the study is currently recruiting at IRCCS National Neurologi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-09-04Clinical Trial Update: Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in Adults [Phase 2]
A Phase 2 trial evaluating the safety and efficacy of ABP-450 for migraine prevention in adults has completed.
-
CLINICAL_TRIALS trial_result · 2024-08-30Clinical Trial Update: Erenumab - Comprehensive Assessment of Efficacy in (High-Frequency) Episodic Migraine [Phase 4]
Phase 4 study updating the efficacy of erenumab (Aimovig) for high-frequency and episodic migraine has completed with results posted.
-
FDA approval · 2024-08-28FDA Approved: DIHYDROERGOTAMINE MESYLATE — Supplemental Application (Provepharm Inc.)
FDA approved a supplemental application for dihydroergotamine mesylate from Provepharm Inc. under ANDA212046.
-
CLINICAL_TRIALS research · 2024-08-27Clinical Trial Update: Open Label, 6-month Study for High Frequency and Chronic Migraine,
This clinical trial update describes an open-label, 6-month study for high-frequency and chronic migraine. The trial is currently active but…
-
CLINICAL_TRIALS research · 2024-08-26Clinical Trial Update: Association of Helicobacter Pylori Infection and Migraine [NA]
Clinical trial investigating the association between Helicobacter pylori infection and migraines in children. The study is currently recruit…
-
CLINICAL_TRIALS research · 2024-08-23Clinical Trial Update: The Effect of Wet Cupping Therapy on Headache and Migraine-related Disability [NA]
A clinical trial is evaluating whether wet cupping therapy can alleviate migraine-related headache and disability; the study is currently no…
-
CLINICAL_TRIALS research · 2024-08-22Clinical Trial Update: Overlapping Pain Trajectory Study
Clinical trial update for an overlapping pain trajectory study that is currently recruiting, focusing on migraine and various chronic pain c…
-
CLINICAL_TRIALS research · 2024-08-20Clinical Trial Update: COACT Study: CGRPmAbs + OnabotulinumtoxinA Assessment of Chronic Migraine Treatments Study [Phase 4]
Phase 4 study assessing chronic migraine treatments by combining CGRP monoclonal antibodies with onabotulinumtoxinA; current status is activ…
-
CLINICAL_TRIALS research · 2024-08-20Clinical Trial Update: Searching for Novel Therapeutic Approaches in Migraine Patients Resistant to Treatments
A clinical trial update shows a recruiting study from IRCCS National Neurological Institute 'C. Mondino' Foundation investigating novel ther…
-
CLINICAL_TRIALS research · 2024-08-20Clinical Trial Update: Searching for Novel Biological Phenotypes in Migraine Patients Resistant to Treatments
A recruiting clinical trial seeking to identify novel biological phenotypes in migraine patients who are resistant to current treatments.
-
CLINICAL_TRIALS research · 2024-08-20Clinical Trial Update: Ubrogepant treatmeNt in mIgraine Patients Utilizing mOnoclonal aNtibodies [Phase 4]
Phase 4 trial update for ubrogepant in migraine patients using monoclonal antibodies; the study is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2024-08-19Clinical Trial Update: An Observational Study to Assess Change in Disease Activity When Ubrogepant Tablets Are Combined With Atogepant Tablets to Treat Migraine in Adult Participants
An observational study assessing changes in migraine disease activity when ubrogepant is combined with atogepant in adult participants.
-
CLINICAL_TRIALS trial_result · 2024-08-14Clinical Trial Update: Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-071) [Phase 3]
This entry describes a completed Phase 3 trial evaluating a marketed drug for menstrual migraine. The sponsor is Organon and Co.
-
CLINICAL_TRIALS trial_result · 2024-08-14Clinical Trial Update: Study to Test an Approved Product in the Early Treatment of Migraine (0462-065) [Phase 3]
A Phase 3 trial (0462-065) tested an approved product for early treatment of migraine and has completed.
-
CLINICAL_TRIALS trial_result · 2024-08-14Clinical Trial Update: Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-072) [Phase 3]
A Phase 3 trial of a marketed drug for menstrual migraine has completed.
-
CLINICAL_TRIALS trial_result · 2024-08-14Clinical Trial Update: Day to Day Variation of Pressure Pain Threshold and Muscle Hardness
This completed clinical trial update investigates day-to-day variation in pressure pain threshold and muscle hardness in individuals with mi…
-
CLINICAL_TRIALS trial_result · 2024-08-14Clinical Trial Update: Study to Test an Approved Product in the Early Treatment of Migraine (0462-066) [Phase 3]
A Phase 3 trial update testing an approved product for early treatment of migraine has completed.
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: Real-life Study of the Efficacy of Management of Migraine Patients After Failure of 2 Prophylactic Treatments
A completed real-world study assessing management strategies for migraine patients after failure of two prophylactic treatments.
-
FDA approval · 2024-08-06FDA Approved: AIMOVIG — Supplemental Application (Amgen Inc)
The FDA approved a supplemental application for AIMOVIG (erenumab-aooe) submitted by Amgen.
-
CLINICAL_TRIALS research · 2024-08-05Clinical Trial Update: Migraine Among Sohag University Students
A clinical trial at Sohag University studying migraine among students is not yet recruiting.